Genome wide association studies (GWAS) have shown that PMS2 is a modifier of age at onset and risk of somatic expansion in Huntington’s disease (HD) (17, 18), a CAG-repeat expansion disorder (19). This evidence concerns the gene PMS2 and Huntington disease.